This content was funded and sponsored by Blueprint Medicines GmbH
Targeting systemic mastocytosis
Update in Haematology session EHA 2022, Prof. Olivier Hermine introduces the session on overcoming the challenges in diagnosis and management of advanced systemic Mastocytosis.
07.2022 INT-BP-MED-AVAASM-22046.1
Lessons learned in the diagnosis of Advanced SM
Update in Haematology session EHA 2022, Prof. Andreas Reiter and Prof. Karl Sotlar discuss the diagnostic challenges of Advanced SM in patients. This session also addresses the issue of disease awareness and how to improve the diagnosis of advanced systemic mastocytosis.
07.2022 INT-BP-MED-AVAASM-22047.1
Management of Advanced SM: The state-of-the-art in the precision medicine era
Update in Haematology session EHA 2022, Dr. Deepti Radia and Prof. Andreas Reiter present the current treatment landscape for patients with advanced systemic mastocytosis and also discuss the latest developments for patient management.
07.2022 INT-BP-MED-AVAASM-22048.1
Clinical Case presentation
Update in Haematology session EHA 2022, Dr. Deepti Radia and Dr Francesco Mannelli present two case studies of patients with advanced systemic mastocytosis and discuss their clinical management.
07.2022 INT-BP-MED-AVAASM-22049.1
